Europe C-reactive Protein Testing Market Size & Outlook
Europe c-reactive protein testing market, 2018-2030 (US$M)
Related Markets
Europe c-reactive protein testing market highlights
- The Europe c-reactive protein testing market generated a revenue of USD 1,400.0 million in 2023.
- The market is expected to grow at a CAGR of 0.3% from 2024 to 2030.
- In terms of segment, immunoturbidimetric assay was the largest revenue generating assay type in 2023.
- Immunoturbidimetric Assay is the most lucrative assay type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 1,400.0 million |
| Market revenue in 2030 | USD 1,427.2 million |
| Growth rate | 0.3% (CAGR from 2023 to 2030) |
| Largest segment | Immunoturbidimetric assay |
| Fastest growing segment | Immunoturbidimetric Assay |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunoturbidimetric Assay, Chemiluminescence Immunoassay, Other Assay Types, ELISA |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG ADR, Danaher Corp, Quest Diagnostics Inc, Siemens Healthineers AG ADR, Abbott Laboratories, Merck KGaA, Zoetis Inc Class A, QuidelOrtho Corp, Horiba Ltd, Getein Biotech, Boditech Med, Randox, Aidian |
Other key industry trends
- In terms of revenue, Europe region accounted for 25.2% of the global c-reactive protein testing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,258.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
C-reactive Protein Testing Market Scope
C-reactive Protein Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe c-reactive protein testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to c-reactive protein testing market will help companies and investors design strategic landscapes.
Immunoturbidimetric assay was the largest segment with a revenue share of 48.59% in 2023. Horizon Databook has segmented the Europe c-reactive protein testing market based on immunoturbidimetric assay, chemiluminescence immunoassay, other assay types, elisa covering the revenue growth of each sub-segment from 2018 to 2030.
Rising incidence of heart-related disorders in the region and supportive government policies, collaborations between public-private market entities, ongoing investigations in the region are expected to drive regional growth.
Funding received from various international organizations such as NIH & WHO for R&D is also anticipated to drive the market. Cancer is a crucial public health burden across the European Union.
According to WHO, there are more than 1.9 million deaths and 3.7 million new cancer cases every year in the European region, hence, there is need for large-scale adoption of POC CRP testing solutions to aid in management of cancer in European region.
Reasons to subscribe to Europe c-reactive protein testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe c-reactive protein testing market databook
-
Our clientele includes a mix of c-reactive protein testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe c-reactive protein testing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe c-reactive protein testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe c-reactive protein testing market size, by country, 2018-2030 (US$M)
Europe C-reactive Protein Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
